Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance

ConditionAdenomyosis of Uterus

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-60

SponsorPeking University Aerospace Center Hospital

About this trial

This study aims to compare the safety and efficacy of segmental power adjustment combined with uterine cavity hydro-isolation in microwave ablation of adenomyosis

Eligibility criteria

Qualifiers

UFs or AM diagnosed by pathology and ultrasound；

Relevant symptoms such asabnormal uterine bleeding, secondary anemia, progressive dysmenorrhea and enlargement of the uterus；

Voluntarily undergo MWA；

a confirmed available safe transabdominal puncture path；

Disqualifiers

Pregnancy or malignancy；

Severe and uncorrectable coagulation disorders；

Severe cardiac, liver, and renal dysfunction；

Anesthesia allergy.

Trial design

Treatments tested in this trial

Peritoneal combined with intrauterine water isolation
Peritoneal water isolation

Treatment groups

137 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Peking University Aerospace Center Hospital

Lead sponsor

Source ClinicalTrials.gov